نتایج جستجو برای: relapsing remitting

تعداد نتایج: 10611  

2016
D B Gandhi Babu Sunanda Chavva Shefali Waghray Neeharika Satya Jyothi Allam Marella Kondaiah

Behçet's disease (BD) is a chronic, relapsing multisystemic vascular condition. Behçet's disease was described by Hulusi Behçet in 1937. This rare multisystem relapsing-remitting inflammatory disease is poorly understood but is thought to be an autoimmune inflammatory vasculitic process in a genetically predisposed population. Diagnosis of Behçet's disease is based on International Criteria of ...

Journal: :Advanced Materials 2022

Metabolic Glycoengineering Immune checkpoint ligand functionalized Schwann cells have great potential to treat multiple sclerosis. In article number 2107392, Kin Man Au, Andrew Z. Wang, and Roland Tisch bioengineer with programmed death 1 (PD-L1) cluster of differentiation 86 (CD86) prevent ameliorate established mouse models chronic relapsing–remitting experimental autoimmune encephalomyelitis...

Journal: :Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine 2001
H Suzuki Y Konishi T Morikawa N Okada M Okumura K Yoshioka M Imanishi S Tanaka S Fujii H Kimihide

は じめに 限局性筋炎(focal myositis: FM)は 四肢, 体幹 における限局性の痛み と腫脹 などの症状 に て発症 し,同 部の生検 な どで診 断 される1~3). 今 回我々は,画 像所見 と生検 にて筋膜 に炎症所 見 を伴 う限局性筋炎の1例 を経験 したので報告 す る. 症 例 患者:28歳,女 性.主 訴:右 下腿部痛,発 熱. 現病 歴:1996年8月 よ り両大腿 部の痛み と発熱 が 出現 したため近 医を受診 した.CK 986IU/l, Ald 10.3mIU/ml,CRP 13.7mg/dlよ り筋炎の疑 いで入院 となった.入 院後,症 状 は自然軽快 し, 検査所見 も正常 とな り退 院した.退 院後 は月1 回程度,大 腿部に限局 した腫 脹 と痛みが出現 し たが,自 然消失す るため経過観察中であった. 1999年8月10日 よ...

2010
Dirk Fitzner Mikael Simons

Multiple sclerosis (MS) is an inflammatory, autoimmune, demyelinating disease of the central nervous system (CNS) that usually starts as a relapsing-remitting disease. In most patients the disease evolves into a chronic progressive phase characterized by continuous accumulation of neurological deficits. While treatment of relapsing-remitting MS (RRMS) has improved dramatically over the last dec...

Journal: :CNS & neurological disorders drug targets 2014
Vitalie Vacaras Zsigmond Z Major Dafin F Muresanu Tibor L Krausz Ioan Marginean Dana A Buzoianu

Glatiramer acetate (GA) is one of the most widely used disease-modifying drugs for the treatment of relapsing-remitting multiple sclerosis; is assumed to have inductor effects on neurotrophic factor expression. One of these neurotrophic factor systems is the brain-derived neurotrophic factor (BDNF)/receptor tyrosine kinase B (TrkB) pathway. Peripheral blood is thought to contain soluble BDNF, a...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید